1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 CAR-T 1.2.3 TCR 1.2.4 TIL Therapies 1.3 Market by Application 1.3.1 Global T-Cell Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Stomach Cancer 1.3.3 Lung Cancer 1.3.4 Colorectal Cancer 1.3.5 Esophagus Cancer 1.3.6 Pancreatic Cancer 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global T-Cell Immunotherapy Market Perspective (2017-2028) 2.2 T-Cell Immunotherapy Growth Trends by Region 2.2.1 T-Cell Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 T-Cell Immunotherapy Historic Market Size by Region (2017-2022) 2.2.3 T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028) 2.3 T-Cell Immunotherapy Market Dynamics 2.3.1 T-Cell Immunotherapy Industry Trends 2.3.2 T-Cell Immunotherapy Market Drivers 2.3.3 T-Cell Immunotherapy Market Challenges 2.3.4 T-Cell Immunotherapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top T-Cell Immunotherapy Players by Revenue 3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2017-2022) 3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2017-2022) 3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by T-Cell Immunotherapy Revenue 3.4 Global T-Cell Immunotherapy Market Concentration Ratio 3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2021 3.5 T-Cell Immunotherapy Key Players Head office and Area Served 3.6 Key Players T-Cell Immunotherapy Product Solution and Service 3.7 Date of Enter into T-Cell Immunotherapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 T-Cell Immunotherapy Breakdown Data by Type 4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2017-2022) 4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028) 5 T-Cell Immunotherapy Breakdown Data by Application 5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2017-2022) 5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America T-Cell Immunotherapy Market Size (2017-2028) 6.2 North America T-Cell Immunotherapy Market Size by Type 6.2.1 North America T-Cell Immunotherapy Market Size by Type (2017-2022) 6.2.2 North America T-Cell Immunotherapy Market Size by Type (2023-2028) 6.2.3 North America T-Cell Immunotherapy Market Share by Type (2017-2028) 6.3 North America T-Cell Immunotherapy Market Size by Application 6.3.1 North America T-Cell Immunotherapy Market Size by Application (2017-2022) 6.3.2 North America T-Cell Immunotherapy Market Size by Application (2023-2028) 6.3.3 North America T-Cell Immunotherapy Market Share by Application (2017-2028) 6.4 North America T-Cell Immunotherapy Market Size by Country 6.4.1 North America T-Cell Immunotherapy Market Size by Country (2017-2022) 6.4.2 North America T-Cell Immunotherapy Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe T-Cell Immunotherapy Market Size (2017-2028) 7.2 Europe T-Cell Immunotherapy Market Size by Type 7.2.1 Europe T-Cell Immunotherapy Market Size by Type (2017-2022) 7.2.2 Europe T-Cell Immunotherapy Market Size by Type (2023-2028) 7.2.3 Europe T-Cell Immunotherapy Market Share by Type (2017-2028) 7.3 Europe T-Cell Immunotherapy Market Size by Application 7.3.1 Europe T-Cell Immunotherapy Market Size by Application (2017-2022) 7.3.2 Europe T-Cell Immunotherapy Market Size by Application (2023-2028) 7.3.3 Europe T-Cell Immunotherapy Market Share by Application (2017-2028) 7.4 Europe T-Cell Immunotherapy Market Size by Country 7.4.1 Europe T-Cell Immunotherapy Market Size by Country (2017-2022) 7.4.2 Europe T-Cell Immunotherapy Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific T-Cell Immunotherapy Market Size (2017-2028) 8.2 Asia-Pacific T-Cell Immunotherapy Market Size by Type 8.2.1 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2017-2022) 8.2.2 Asia-Pacific T-Cell Immunotherapy Market Size by Type (2023-2028) 8.2.3 Asia-Pacific T-Cell Immunotherapy Market Share by Type (2017-2028) 8.3 Asia-Pacific T-Cell Immunotherapy Market Size by Application 8.3.1 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2017-2022) 8.3.2 Asia-Pacific T-Cell Immunotherapy Market Size by Application (2023-2028) 8.3.3 Asia-Pacific T-Cell Immunotherapy Market Share by Application (2017-2028) 8.4 Asia-Pacific T-Cell Immunotherapy Market Size by Region 8.4.1 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2017-2022) 8.4.2 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America T-Cell Immunotherapy Market Size (2017-2028) 9.2 Latin America T-Cell Immunotherapy Market Size by Type 9.2.1 Latin America T-Cell Immunotherapy Market Size by Type (2017-2022) 9.2.2 Latin America T-Cell Immunotherapy Market Size by Type (2023-2028) 9.2.3 Latin America T-Cell Immunotherapy Market Share by Type (2017-2028) 9.3 Latin America T-Cell Immunotherapy Market Size by Application 9.3.1 Latin America T-Cell Immunotherapy Market Size by Application (2017-2022) 9.3.2 Latin America T-Cell Immunotherapy Market Size by Application (2023-2028) 9.3.3 Latin America T-Cell Immunotherapy Market Share by Application (2017-2028) 9.4 Latin America T-Cell Immunotherapy Market Size by Country 9.4.1 Latin America T-Cell Immunotherapy Market Size by Country (2017-2022) 9.4.2 Latin America T-Cell Immunotherapy Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa T-Cell Immunotherapy Market Size (2017-2028) 10.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type 10.2.1 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2017-2022) 10.2.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2023-2028) 10.2.3 Middle East & Africa T-Cell Immunotherapy Market Share by Type (2017-2028) 10.3 Middle East & Africa T-Cell Immunotherapy Market Size by Application 10.3.1 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2017-2022) 10.3.2 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2023-2028) 10.3.3 Middle East & Africa T-Cell Immunotherapy Market Share by Application (2017-2028) 10.4 Middle East & Africa T-Cell Immunotherapy Market Size by Country 10.4.1 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2017-2022) 10.4.2 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Adaptimmune 11.1.1 Adaptimmune Company Details 11.1.2 Adaptimmune Business Overview 11.1.3 Adaptimmune T-Cell Immunotherapy Introduction 11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2017-2022) 11.1.5 Adaptimmune Recent Developments 11.2 Altor Bioscience Corporation 11.2.1 Altor Bioscience Corporation Company Details 11.2.2 Altor Bioscience Corporation Business Overview 11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction 11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2017-2022) 11.2.5 Altor Bioscience Corporation Recent Developments 11.3 Cellectis 11.3.1 Cellectis Company Details 11.3.2 Cellectis Business Overview 11.3.3 Cellectis T-Cell Immunotherapy Introduction 11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2017-2022) 11.3.5 Cellectis Recent Developments 11.4 Juno Therapeutics 11.4.1 Juno Therapeutics Company Details 11.4.2 Juno Therapeutics Business Overview 11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction 11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022) 11.4.5 Juno Therapeutics Recent Developments 11.5 Kite Pharma 11.5.1 Kite Pharma Company Details 11.5.2 Kite Pharma Business Overview 11.5.3 Kite Pharma T-Cell Immunotherapy Introduction 11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2017-2022) 11.5.5 Kite Pharma Recent Developments 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis T-Cell Immunotherapy Introduction 11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2017-2022) 11.6.5 Novartis Recent Developments 11.7 Takara Bio 11.7.1 Takara Bio Company Details 11.7.2 Takara Bio Business Overview 11.7.3 Takara Bio T-Cell Immunotherapy Introduction 11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2017-2022) 11.7.5 Takara Bio Recent Developments 11.8 Unum Therapeutics 11.8.1 Unum Therapeutics Company Details 11.8.2 Unum Therapeutics Business Overview 11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction 11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022) 11.8.5 Unum Therapeutics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of CAR-T Table 3. Key Players of TCR Table 4. Key Players of TIL Therapies Table 5. Global T-Cell Immunotherapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global T-Cell Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million) Table 8. Global T-Cell Immunotherapy Market Share by Region (2017-2022) Table 9. Global T-Cell Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global T-Cell Immunotherapy Market Share by Region (2023-2028) Table 11. T-Cell Immunotherapy Market Trends Table 12. T-Cell Immunotherapy Market Drivers Table 13. T-Cell Immunotherapy Market Challenges Table 14. T-Cell Immunotherapy Market Restraints Table 15. Global T-Cell Immunotherapy Revenue by Players (2017-2022) & (US$ Million) Table 16. Global T-Cell Immunotherapy Revenue Share by Players (2017-2022) Table 17. Global Top T-Cell Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2021) Table 18. Ranking of Global Top T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by T-Cell Immunotherapy Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players T-Cell Immunotherapy Product Solution and Service Table 22. Date of Enter into T-Cell Immunotherapy Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 25. Global T-Cell Immunotherapy Revenue Market Share by Type (2017-2022) Table 26. Global T-Cell Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global T-Cell Immunotherapy Revenue Market Share by Type (2023-2028) Table 28. Global T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 29. Global T-Cell Immunotherapy Revenue Share by Application (2017-2022) Table 30. Global T-Cell Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global T-Cell Immunotherapy Revenue Share by Application (2023-2028) Table 32. North America T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 33. North America T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 34. North America T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 35. North America T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 36. North America T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 37. North America T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific T-Cell Immunotherapy Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa T-Cell Immunotherapy Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa T-Cell Immunotherapy Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa T-Cell Immunotherapy Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa T-Cell Immunotherapy Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa T-Cell Immunotherapy Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa T-Cell Immunotherapy Market Size by Country (2023-2028) & (US$ Million) Table 62. Adaptimmune Company Details Table 63. Adaptimmune Business Overview Table 64. Adaptimmune T-Cell Immunotherapy Product Table 65. Adaptimmune Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 66. Adaptimmune Recent Developments Table 67. Altor Bioscience Corporation Company Details Table 68. Altor Bioscience Corporation Business Overview Table 69. Altor Bioscience Corporation T-Cell Immunotherapy Product Table 70. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 71. Altor Bioscience Corporation Recent Developments Table 72. Cellectis Company Details Table 73. Cellectis Business Overview Table 74. Cellectis T-Cell Immunotherapy Product Table 75. Cellectis Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 76. Cellectis Recent Developments Table 77. Juno Therapeutics Company Details Table 78. Juno Therapeutics Business Overview Table 79. Juno Therapeutics T-Cell Immunotherapy Product Table 80. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 81. Juno Therapeutics Recent Developments Table 82. Kite Pharma Company Details Table 83. Kite Pharma Business Overview Table 84. Kite Pharma T-Cell Immunotherapy Product Table 85. Kite Pharma Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 86. Kite Pharma Recent Developments Table 87. Novartis Company Details Table 88. Novartis Business Overview Table 89. Novartis T-Cell Immunotherapy Product Table 90. Novartis Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 91. Novartis Recent Developments Table 92. Takara Bio Company Details Table 93. Takara Bio Business Overview Table 94. Takara Bio T-Cell Immunotherapy Product Table 95. Takara Bio Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 96. Takara Bio Recent Developments Table 97. Unum Therapeutics Company Details Table 98. Unum Therapeutics Business Overview Table 99. Unum Therapeutics T-Cell Immunotherapy Product Table 100. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Table 101. Unum Therapeutics Recent Developments Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global T-Cell Immunotherapy Market Share by Type: 2021 VS 2028 Figure 2. CAR-T Features Figure 3. TCR Features Figure 4. TIL Therapies Features Figure 5. Global T-Cell Immunotherapy Market Share by Application: 2021 VS 2028 Figure 6. Stomach Cancer Case Studies Figure 7. Lung Cancer Case Studies Figure 8. Colorectal Cancer Case Studies Figure 9. Esophagus Cancer Case Studies Figure 10. Pancreatic Cancer Case Studies Figure 11. Others Case Studies Figure 12. T-Cell Immunotherapy Report Years Considered Figure 13. Global T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global T-Cell Immunotherapy Market Share by Region: 2021 VS 2028 Figure 16. Global T-Cell Immunotherapy Market Share by Players in 2021 Figure 17. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2021) Figure 18. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2021 Figure 19. North America T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 20. North America T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 21. North America T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 22. North America T-Cell Immunotherapy Market Size Share by Country (2017-2028) Figure 23. United States T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 26. Europe T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 27. Europe T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 28. Europe T-Cell Immunotherapy Market Size Share by Country (2017-2028) Figure 29. Germany T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. France T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. U.K. T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Italy T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Russia T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Nordic Countries T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 36. Asia Pacific T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 37. Asia Pacific T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 38. Asia Pacific T-Cell Immunotherapy Market Size Share by Region (2017-2028) Figure 39. China T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Japan T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. South Korea T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. India T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Australia T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 45. Latin America T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 46. Latin America T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 47. Latin America T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 48. Latin America T-Cell Immunotherapy Market Size Share by Country (2017-2028) Figure 49. Mexico T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Brazil T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Middle East & Africa T-Cell Immunotherapy Market Size YoY (2017-2028) & (US$ Million) Figure 52. Middle East and Africa T-Cell Immunotherapy Market Size Market Share by Type (2017-2028) Figure 53. Middle East and Africa T-Cell Immunotherapy Market Size Market Share by Application (2017-2028) Figure 54. Middle East and Africa T-Cell Immunotherapy Market Size Share by Country (2017-2028) Figure 55. Turkey T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Saudi Arabia T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. UAE T-Cell Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022) Figure 59. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022) Figure 60. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022) Figure 61. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022) Figure 62. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022) Figure 63. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022) Figure 64. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022) Figure 65. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Adaptimmune Altor Bioscience Corporation Cellectis Juno Therapeutics Kite Pharma Novartis Takara Bio Unum Therapeutics